Waters Corporation receives FDA clearance for at-home HPV Self-Collection Kit.

{
  "signal_id": "6ec1ff1c-fe32-45d7-b3bb-79218cce531f",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-04-08T00:00:00+00:00",
  "company": {
    "name": "Waters",
    "domain": "waters.com"
  },
  "data": {
    "url": "https://www.healthcarepackaging.com/industry-news/regulatory/article/22964342/waters-corporation-receives-fda-clearance-for-athome-hpv-selfcollection-kit",
    "title": "Waters Corporation receives FDA clearance for at-home HPV Self-Collection Kit.",
    "excerpt": "Waters Corporation receives FDA clearance for at-home HPV Self-Collection Kit.\n\nThe regulatory decision enables a shift in cervical cancer screening from clinical settings to patients' homes, creating new operational models and market opportunities for diagnostic labs and healthcare providers.\n\nApr 8, 2026\n\nWaters announces FDA clearance of the Onclarity HPV Self-Collection Kit and approval of the BD Onclarity HPV Assay with extended genotyping for at-home use, marking a significant milestone in expanding access to cervical cancer screening.\n\nKey Takeaways:\n\n* The FDA's clearance of an at-home, prescription-based HPV test signals a broader regulatory acceptance of decentralized diagnostic models, impacting how providers and labs manage patient screening.\n* The direct-to-patient distribution model, covered by major insurers, opens a new revenue channel and expands the addressable market by targeting the estimated 60% of individuals who are unscreened or under-screened.\n* Successful implementation at scale will depend on high-throughput laboratory automation, such as the BD COR(TM) System, to efficiently process an influx of self-collected samples and ensure reliable results.\n\nThe U.S. Food and Drug Administration has cleared an at-home self-collection kit for human papillomavirus (HPV) screening, a development that stands to alter the landscape for diagnostic companies...",
    "product": "Onclarity HPV Self-Collection Kit",
    "summary": "Waters Corporation launched Onclarity HPV Self-Collection Kit on Apr 8th '26.",
    "category": "launches",
    "found_at": "2026-04-08T00:00:00Z",
    "planning": false,
    "image_url": "https://img.healthcarepackaging.com/mindful/pmmi/workspaces/default/uploads/2026/04/waters-corporation-onclarity-hpv-self-collection-kit.ZXlbbdOVW6.jpg?auto=format%2Ccompress&h=630&q=70&w=1200",
    "confidence": 0.442,
    "product_data": {
      "full_text": "Onclarity HPV Self-Collection Kit",
      "fuzzy_match": true
    },
    "published_at": "2026-04-08T00:00:00Z",
    "effective_date": "2026-04-08",
    "job_title_tags": [
      "finance"
    ],
    "article_sentence": "Waters Corporation announced on Wednesday that its Onclarity HPV Self-Collection Kit, used with the BD Onclarity HPV Assay, received clearance, allowing for prescription-based distribution directly to patients."
  }
}

curl https://signals.autobound.ai/v1/signals/6ec1ff1c-fe32-45d7-b3bb-79218cce531f \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"waters.com","limit":20}'